@STHanMD

Peds rheumatologist. Mother. Wife. 🏖 & 🐶 lover. 👁🦵🏼researcher ➡️ #uveitis, #pedsrheum, #jia @CincyChildrens Views expressed are my own. 🇵🇭🇺🇸

 Cincinnati, OH
Joined March 2018
  • Tweets1.1K
  • Following758
  • Followers873
68Media
Our new📝 reports on biomarkers in #tearfluid 💧of 👧🏻🧒🏻 with #jia based on #uveitis diagnosis. Several are associated with the RPE & blood retinal barrier, and previously detected in aqueous humor. #pedsrheum @GrantSchulert tandfonline.com/doi/full/10.…

Candidate Tear-Based Uveitis Biomarkers in Children with JIA Based on Arthritis Activity and...

Uveitis is an inflammatory ocular disease secondary to disruption of the retinal pigmented epithelium (RPE) and blood retinal barrier (BRB). Known clinical factors do not accurately predict uveitis...

tandfonline.com
1
4
18
505
Calling all early-career researchers! The @CureArthritis 2025 grants are open for applications on Nov 4. From Psoriatic Arthritis to Pediatric Rheumatology, these grants fund game-changing research. Apply today: CureArthritis.org/Research-G… #ArthritisResearch #Rheumatology #pedsrheum

Arthritis Research Grants | Arthritis National Research Foundation

The Arthritis National Research Foundation provides arthritis research grants for research scientists. If you're looking for arthritis research grants see the options here.

curearthritis.org
8
17
623
Honored to join the Scientific Advisory Board of Arthritis National Research Foundation! @CureArthritis Mission: Provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. #jia #pedsrheum #uveitis
2
3
1
19
1,054
We newly report in 8👧🏻🧒🏻 w/ Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy ➡️Systemic treatment w/ MTX, IFX, TCZ ➡️ 👁️ outcomes W/ Arjun Sood @GrantSchulert #ADNIV #uveitis #pedsrheum ➡️tandfonline.com/doi/full/10.…

Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammat...

Autosomal dominant neovascular inflammatory vitreoretinopathy (NIV), formerly called “ADNIV,” is a rare autoinflammatory condition mainly of adulthood caused by mutations in calcium-activated calpa...

tandfonline.com
1
11
355
Sheila Angeles-Han retweeted
Ekemini Ogbu MD MSc@PRheumdoc19 Aug 2024
Results of our recent study on Tofacitinib in JIA @NetworkPrcsg @jaymehtamd @GrantSchulert @STHanMD @HermineBrunner0 @LauraLewMad11 @MymaAlbaydaMD @rheum_cat @Prahalpedrheum @HarryGewanter
ACR_Journals
@ACR_Journals19 Aug 2024
No blood-based biomarkers could be identified to predict response to JAK inhibition (tofacitinib) in polyarticular JIA; however, an association of HLA-B27 positivity with lower tofacitinib response may warrant further study In AC&R loom.ly/EuPePSI @PRheumdoc
Supplemental Figure 1: Box plots of the levels of the log10-transformied CBB in 143 patients with JIA comparing responders (R; n = 50 ) to non-responders (NR; n = 93) at baseline and after 18 weeks of tofacitinib treatment.

ALT Supplemental Figure 1: Box plots of the levels of the log10-transformied CBB in 143 patients with JIA comparing responders (R; n = 50 ) to non-responders (NR; n = 93) at baseline and after 18 weeks of tofacitinib treatment.

3
14
692
We report that 84% of 110 👦🏻👧🏻 w/ tubulointerstitial nephritis + uveitis syndrome needed IMT (45% biologics). Younger age, male sex and ⬆️ uveitis grade were associated with use of 2 or more IMT. nature.com/articles/s41433-0…

Clinical outcomes in paediatric tubulointerstitial nephritis and uveitis syndrome (TINU)

Eye - Clinical outcomes in paediatric tubulointerstitial nephritis and uveitis syndrome (TINU)

nature.com
2
159
Congratulations to all these amazing new @carrainc grant awardees including my @CincyChildrens colleagues @STHanMD Dani Schocken and Jackie Rodriguez-Smith! @CincyKidsOAACD @CincyResearch
CARRA@carrainc15 Jul 2024
🌟 Congratulations to the winners of this year's CARRA-Arthritis Foundation grants! Thank you to the @ArthritisFdn for partnering with us to help advance pediatric rheumatology research. Read the full story ➡️ carragroup.org/blog/arthriti…
3
12
747
We report novel UWFFA & OCT findings in children with autosomal dominant neovascular inflammatory vitreoretinopathy-ADNIV & steroid response. EARLY CAPN5 testing, screening for #uveitis & retinal vasculitis, & tx may alter the natural history #pedsrheum sciencedirect.com/science/ar…
3
8
541
A simplified approach to uveitis screening when JIA category and ANA status are unknown. Young children with JIA who are recently diagnosed are at greatest risk. #pedsrheum #uveitis #jia @AntonJordi68 @lolaeyedoc @uveitisharry
Ophthalmology at BMJ
@BMJ_Ophth19 Apr 2024
The Multinational Interdisciplinary Working Group for Uveitis in Childhood experts developed a simplified and practical #uveitis screening guide for patients with juvenile idiopathic arthritis (JIA) associated uveitis, read here: bit.ly/3xxIwok #rheum #eyes #pediatrics
3
18
1,158
Sheila Angeles-Han retweeted
USSONAR@USSONAR_Rh2 Feb 2024
.@Patricia_VegaF teaching elbow ultrasound with the newest Clarius hand held. Thanks @clariusmhealth for your support of our course #POCUS #ultrasound #medtwitter #rheumatology #joints #tendons – at Tampa, FL
7
1
10
1,036
Sheila Angeles-Han retweeted
Edmund Tsui, MD@EdmundTsuiMD8 Oct 2023
Excited for our session in the @ARVOinfo Biomarkers Conference: OCT-based quantification of anterior chamber inflammation: what next? Speakers: ➡️@lolaeyedoc @GoshSight ➡️SriniVas Sadda @DohenyEye ➡️@STHanMD @CincyChildrens ➡️Douglas Jabs @JohnsHopkinsSPH ➡️Me! @UCLASteinEye
ARVO@ARVOinfo5 Oct 2023
Attention basic/clinician-scientists! Sign up for @ARVOinfo's virtual Biomarkers Conference (Nov. 8-9) to explore the current/future role of #biomarkers in diagnosing, treating and curing #oculardisorders. Register today: bit.ly/44rH0yV #ARVOeducation #visionresearch
2
4
14
2,073
Sheila Angeles-Han retweeted
Michael F. Chiang, MD@NEIDirector6 Sep 2023
From @PittTweet @PittPubHealth @MassEyeAndEar @HMSEye @JohnKempen3 and collaborators: No evidence of excess risk of cancer in patients who took immunosuppressant medications for inflammatory eye diseases (short-term courses). #NEIfunded @BMJOncology: bit.ly/3OYZFMI
Jeanine Buchanich, University of Pittsburgh, and John Kempen, Mass Eye and Ear

ALT Jeanine Buchanich, University of Pittsburgh, and John Kempen, Mass Eye and Ear

Jeanine Buchanich, University of Pittsburgh, and John Kempen, Mass Eye and Ear

ALT Jeanine Buchanich, University of Pittsburgh, and John Kempen, Mass Eye and Ear

6
1
11
2,884
Excited and honored to be selected for this amazing opportunity - AMP AIM Team Science LSP in Women’s Health! @OMRF @NIH_NIAMS @NIH_ORWH @NIHDataScience @CincyChildrens @NatEyeInstitute #uveitis #jia #pedsrheum
NIAMS@NIH_NIAMS31 Aug 2023
In collaboration with @NIH_ORWH and @NIHDataScience, NIAMS is excited to announce the inaugural cohort of the Team Science Leadership Scholars Program in Women’s Health. Read our recently published Director’s letter to learn more about the program: go.nih.gov/cebDuBY

Announcing the Inaugural Cohort of Leadership Scholars Program Awardees

Dear Colleagues, Many studies have shown that autoimmune diseases disproportionately affect women – nearly 80 percent of those with an autoimmune disease are women. Better understanding these types...

niams.nih.gov
9
4
22
2,888
Sheila Angeles-Han retweeted
CARRA@carrainc5 Jun 2023
Do you or your child have #juvenilearthritis and are you 18 or older? If yes, please complete this brief survey surveymonkey.com/r/Y8C8HNY to help @carrainc & @ArthritisFdn select future research projects that matter most to you. Participation is completely voluntary #jiaresearch
10
13
1,507
Sheila Angeles-Han retweeted
Eryn Marchiolo@emarchiolo2 May 2023
The Foundation for Research in Rheumatology (FOREUM) and @RheumResearch are jointly issuing a call for apps highlighting funds to support research benefitting from collabs between investigators residing in both the U.S. and Europe. Info: rheumresearch.org/innovative…
10
12
2,731
Sheila Angeles-Han retweeted
Eric Dein@ericdeinmd29 Apr 2023
Replying to @jeffsparks
@jeffsparks New indications for autoimmune medications and new recent pediatric indications #ACRX23 #SOTA @RheumNow
2
6
300
Sheila Angeles-Han retweeted
Eric Dein@ericdeinmd29 Apr 2023
HCQ safety: <5mg/kg/d leads to flare risk >5mg/kg leads to higher 👀 risk 1/5 with retinal toxicity at 15 years for >6 mg/kg @jeffsparks #ACRX23 #SOTA @RheumNow
16
33
2,898
Finally! Excited to see this in print: Efficacy and safety of emapalumab in macrophage activation syndrome | Annals of the Rheumatic Diseases ard.bmj.com/content/early/20…
4
18
2
74
9,332
Sheila Angeles-Han retweeted
Dr Rheum@rheumdoctor31 Mar 2023
How to approach refractory #uveitis? #PRSYM23
1
13
28
2,852
Sheila Angeles-Han retweeted
Eve smith@evemdsmith_eve19 Mar 2023
CALLING ALL PAEDIATRIC RHEUMATOLOGIST & RESEARCHERS 📣I am doing a presentation at PRSYM on collaboration and have put together a short 3 Q survey to collect opinions ‘Why, how and the future?’ I am sure you will all have very valuable ideas! Please see forms.office.com/e/h85fAAQXE…
2
11
3
29
4,709
Load more